Clinical Trials for Prinicipal Investigator: Lauren C Pinter-Brown

4 Open Trials. Phone:(877.827.8839)
Protocol No. Title Status
UCI-16-46 A Phase I dose-ranging study to investigate the safety, tolerability and pharmacokinetics of MRG-106 following local intratumoral, subcutaneous, and intravenous administration in subjects with various lymphomas and leukemias Open
UCI-17-36 A Clinical Study to Demonstrate Safety and Efficacy of E7777 in Persistent or Recurrent Cutaneous T-Cell Lymphoma Open
UCI-17-70 A Phase 2b Randomized Study to Assess the Efficacy and Safety of the Combination of Ublituximab + TGR-1202 with or without Bendamustine and TGR-1202 alone in Patients with Previously Treated Non-HodgkinÂ’s Lymphoma Open
UCI-17-82 A Randomized, Double-Blind, Multi-Centre, Placebo-Controlled, Parallel-Arm Phase II Trial to Assess Safety, Efficacy and Pharmacokinetics of CD11301 0.03% and 0.06% Gel in the Treatment of Cutaneous T-Cell Lymphoma (CTCL), Stages IA, IB and IIA Open